Holding Big Pharma Accountable Remains Top Priority for American Voters Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday ahead of President Biden’s introduction of the “American Families Plan” in an address to Congress. “We thank the President for correctly recognizing the importance of solutions to lower out-of-control drug prices and […]
Congress and the Administration Must Act on Solutions that Have Won Bipartisan Support to Deliver Relief for American Patients and Consumers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the reintroduction of the Elijah E. Cummings Lower Drug Costs Now Act (HR3) in the U.S. House of Representatives. “The […]
Lawmakers Pass Pair of Bills Aimed at Boosting Generic and Biosimilar Competition Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday applauding the passage of the Ensuring Innovation Act and the Advancing Education on Biosimilars Act of 2021 in the U.S. House of Representatives on Wednesday. Both bills passed out of […]
Campaign Will Highlight Impact of Out-of-Control Drug Prices, Especially in Areas like Oncology, and the Urgency to Hold Big Pharma Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched a campaign Tuesday encouraging policymakers to act on campaign promises to hold Big Pharma accountable and lower prescription drug prices. “Out-of-control prescription drug […]
Government Report Finds No Relationship Between Drug Company R&D and Prescription Drug Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday responding to a new report from the Congressional Budget Office (CBO) titled “Research and Development in the Pharmaceutical Industry,” which confirms that pharmaceutical research and development (R&D) costs […]
Legislation Will Boost Transparency to Hold Big Pharma Accountable for Egregious Pricing Practices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today applauding the reintroduction of The Fair Accountability and Innovative Research (FAIR) Drug Pricing Act in the U.S. Senate. “Greater list price transparency will help crack down on Big Pharma’s […]
Lawmakers on HELP Subcommittee Can Add to Bipartisan Momentum to Hold Big Pharma Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today ahead of a hearing on prescription drug prices scheduled for Tuesday before the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) Subcommittee on Primary Health and […]
Campaign Looks Forward to Working with Secretary Becerra to Lower Drug Prices and Hold Big Pharma Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today after the United States Senate voted to confirm Xavier Becerra as the next Secretary of the U.S. Department of Health and Human Services (HHS). “CSRxP […]
Big Pharma CFO Hypes “Significant Opportunity” From “Pricing Perspective” Post-Pandemic Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today reacting to the latest comments from Pfizer Chief Financial Officer Frank D’Amelio hyping the company’s “significant opportunity” to hike vaccine prices to boost profits post-pandemic. “Pfizer continues to openly hype its intention to […]
Big Pharma Has Already Repeatedly Hiked Drug Prices During Public Health Crisis, Now Drug Companies Are Eyeing Chance to Price-Gouge Vaccines Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today reacting to comments from Pfizer Chief Financial Officer Frank D’Amelio promising to hike the price of the company’s COVID-19 vaccine […]